Press release
Wet Age-Related Macular Degeneration Pipeline Insights, 2022 | Clinical and Non-Clinical Trials, Emerging Therapies, Treatment Algorithm, and Key Companies Assessment
As per DelveInsight's assessment, globally, about 70+ key pharma and biotech companies are working on 80+ pipeline drugs in the Wet Age-Related Macular Degeneration (Wet-AMD) therapeutics landscape based on different Routes of Administration (RoA), Mechanism of Action (MoA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years."Wet Age-Related Macular Degeneration (Wet-AMD) Pipeline Insight, 2022" report by DelveInsight provides a comprehensive analysis of the ongoing clinical development activities and growth prospects across the Wet Age-Related Macular Degeneration Therapeutics Market.
The report provides a detailed description of the drug, including the mechanism of action, type, stage, route of administration, molecule type, clinical studies, inactive pipeline products, and NDA approvals (if any).
The report also covers commercial and clinical activities of the pipeline products from the pre-clinical developmental phase to the marketed stage. Additionally, it presents the ongoing developments in the therapeutics segment, including collaborations, licensing, mergers & acquisitions (M&A), funding, designations, and other product-related details.
Wet Age-Related Macular Degeneration (Wet-AMD) Pipeline Analysis
The report provides insights into:
• The report provides detailed insights into the key companies that are developing therapies in the Wet Age-Related Macular Degeneration Market.
• The report also evaluates different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Wet Age-Related Macular Degeneration treatment.
• It analyzes the key companies involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• It navigates the emerging drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Wet Age-Related Macular Degeneration market.
The report is built using data and information traced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.
DelveInsight's Report covers around 80+ products under different phases of clinical development like
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued & Inactive candidates
Request for Sample PDF to Understand More About the Treatment Outlook and Future Perspectives:
https://www.delveinsight.com/report-store/wet-age-related-macular-degeneration-wet-amd-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Wet Age-Related Macular Degeneration (Wet-AMD) Therapeutics Analysis
There are approx. 70+ key companies developing therapies for Wet Age-Related Macular Degeneration (Wet-AMD). Currently, Luye Pharma has its Wet Age-Related Macular Degeneration (Wet-AMD) drug candidates in the most advanced stage of clinical development.
Key companies in the Wet Age-Related Macular Degeneration (Wet-AMD) Market include
Opthea Limited, Outlook Therapeutics, Kodiak Sciences, Regenxbio, Dobecure, Gemini Therapeutics, Huabo Biopharm, Isarna Therapeutics, IVERIC bio (formerly Ophthotech Corporation), Tasly Pharmaceutical Group, Ribomic, Innovent Biologics, GrayBug Vision, Curacle, Quark Pharmaceuticals, Bio-Thera Solutions, AngioLab Inc, Alkahest, Tyrogenex, Iconic Therapeutics, AiViva BioPharma, Boehringer Ingelheim, RemeGen, PanOptica, Clearside Biomedical, Feramda, AsclepiX Therapeutics, Unity Biotechnology, Kyowa Kirin, Ocular Therapeutix, Janssen Research & Development, EyePoint Pharmaceuticals, Shanghai Biomabs Pharmaceutical, Aerie Pharmaceuticals, Ashvattha Therapeutics, Roche, Noveome, Sunshine Guojian Pharmaceutical (Shanghai), Adverum Biotechnologies, Zhaoke Ophthalmology, 4D Molecular Therapeutics, Abpro Corporation, Novelty Nobility, Kala Pharmaceuticals, Surrozen, Samjin Pharm, and many others.
Wet Age-Related Macular Degeneration (Wet-AMD) Drugs Covered in the report include:
• LY09004: Luye Pharma
• KSI-301: Kodiak Sciences
• GEM-103: Gemini Therapeutics
• Zimura: Iveric Bio
• RC 28 E: RemeGen
• BI 836880: Boehringer Ingelheim
• AAVCAGsCD59: Janssen Research and Development
And many more
Download Sample Pages to Get an in-depth Assessment of the Emerging Therapies and Key Companies:
https://www.delveinsight.com/sample-request/wet-age-related-macular-degeneration-wet-amd-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Table of Content
1. Report Introduction
2. Executive Summary
3. Wet Age-Related Macular Degeneration Current Treatment Patterns
4. Wet Age-Related Macular Degeneration - DelveInsight's Analytical Perspective
5. Therapeutic Assessment
6. Wet Age-Related Macular Degeneration Late Stage Products (Phase-III)
7. Wet Age-Related Macular Degeneration Mid-Stage Products (Phase-II)
8. Early Stage Products (Phase-I)
9. Pre-clinical Products and Discovery Stage Products
10. Inactive Products
11. Dormant Products
12. Wet Age-Related Macular Degeneration Discontinued Products
13. Wet Age-Related Macular Degeneration Product Profiles
14. Wet Age-Related Macular Degeneration Key Companies
15. Wet Age-Related Macular Degeneration Key Products
16. Dormant and Discontinued Products
17. Wet Age-Related Macular Degeneration Unmet Needs
18. Wet Age-Related Macular Degeneration Future Perspectives
19. Wet Age-Related Macular Degeneration Analyst Review
20. Appendix
21. Report Methodology
*The table of contents is not exhaustive; the final content may vary.
Request the Sample PDF to Get Detailed Insights About the Reports Offerings:
https://www.delveinsight.com/sample-request/wet-age-related-macular-degeneration-wet-amd-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Contact Info:
Shruti Thakur
Manager - Marketing & International Branding
Email: info@delveinsight.com
Request for Sample Copy of the Report at:
https://www.delveinsight.com/sample-request/wet-age-related-macular-degeneration-wet-amd-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
428, D21 Corporate Park, Sector-21, Dwarka, New Delhi-110077, India
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Wet Age-Related Macular Degeneration Pipeline Insights, 2022 | Clinical and Non-Clinical Trials, Emerging Therapies, Treatment Algorithm, and Key Companies Assessment here
News-ID: 2802793 • Views: …
More Releases from DelveInsight Business Research
Chemotherapy Induced Nausea and Vomiting Pipeline 2025: Therapies Under Investig …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Chemotherapy Induced Nausea and Vomiting pipeline constitutes 4+ key companies continuously working towards developing 6+ Chemotherapy Induced Nausea and Vomiting treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Chemotherapy Induced Nausea and Vomiting Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical…
Desmoid Tumors Market to Expand Significantly by 2034, States DelveInsight Repor …
DelveInsight's "Desmoid Tumors Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Desmoid Tumors, historical and forecasted epidemiology as well as the Desmoid Tumors market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Desmoid Tumors market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Desmoid Tumors Market Forecast
https://www.delveinsight.com/sample-request/desmoid-tumors-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the key…
Extensive-Stage Small Cell Lung Cancer Pipeline 2025: MOA, ROA, FDA-Approved Dru …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Extensive-Stage Small Cell Lung Cancer pipeline constitutes 25+ key companies continuously working towards developing 30+ Extensive-Stage Small Cell Lung Cancer treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"Extensive-Stage Small Cell Lung Cancer Pipeline Insight, 2025" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and…
Pancreatic Cancer Market Growth Projections 2024-2034: DelveInsight Analysis
The Pancreatic Cancer market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage pipeline products will significantly revolutionize the Pancreatic Cancer market dynamics.
DelveInsight's "Pancreatic Cancer Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of Pancreatic Cancer, historical and forecasted epidemiology as well as the Pancreatic Cancer market trends in the United States, EU5 (Germany,…
More Releases for Wet
Wet Age-Related Macular Degeneration (Wet AMD) market is expected to reach USD 1 …
Wet age-related macular degeneration (Wet AMD) is a chronic, progressive eye disorder and one of the leading causes of severe vision loss in people over 60. Unlike the dry form of AMD, Wet AMD is characterized by the growth of abnormal blood vessels under the retina that leak fluid or blood, leading to rapid central vision loss. While Wet AMD accounts for only about 10-15% of all AMD cases, it…
Wet And Cold Appliance Market Size Analysis by Application, Type, and Region: Fo …
USA, New Jersey- According to Market Research Intellect, the global Wet And Cold Appliance market in the Internet, Communication and Technology category is projected to witness significant growth from 2025 to 2032. Market dynamics, technological advancements, and evolving consumer demand are expected to drive expansion during this period.
The wet and cold appliance market is expanding steadily, driven by changing consumer lifestyles, increasing urbanization, and rising demand for home automation. Appliances…
Semiconductor Electronic Wet Chemicals Market
Semiconductor Electronic Wet Chemicals Market Overview
Electronic wet chemicals are ultra-pure nature due to which they are extensively used in cleaning and etching application during semiconductor production and processing.
This report provides a deep insight into the global Semiconductor Electronic Wet Chemicals market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market…
Wet and Dry Vacuum Cleaner Market
The "Wet and Dry Vacuum Cleaner Market" is expected to reach USD xx.x billion by 2031, indicating a compound annual growth rate (CAGR) of xx.x percent from 2024 to 2031. The market was valued at USD xx.x billion In 2023.
Growing Demand and Growth Potential in the Global Wet and Dry Vacuum Cleaner Market, 2024-2031
Verified Market Research's most recent report, "Wet and Dry Vacuum Cleaner Market: Global Industry Trends, Share, Size,…
Wet Filtered Downdraught Workbench Market
Wet filtered downdraught workbench is the industry's leading solution for the collection of combustible metal dust which can safely removes combustible materials while complying with NFPA and OSHA combustible dust guidelines.
The global Wet Filtered Downdraught Workbench market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine…
Corn Wet-milling Market Corn Wet Milling Market Share, Size, Demand, Key Players …
Market Analysis and Insights of Global Corn Wet-milling Market
The corn wet-milling market is expected to witness market growth at a rate of 5.70% in the forecast period of 2022 to 2029. Data Bridge Market Research report on corn wet-milling market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market's growth. The growth in awareness globally is…
